IP Library Granted Patent US 9,567,609
Granted Patent B2
US 9,567,609 · App. 14/471,782 · Granted Feb 14, 2017

Compositions for linking DNA-binding domains and cleavage domains

Inventors: David Paschon (Richmond, CA); Lei Zhang (Richmond, CA)
Assignee: Sangamo BioSciences, Inc.
C12N15/907C12N9/22C12N15/01C07K2319/81
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,567,609
App. No.
14/471,782
Granted
Feb 14, 2017
Kind
B2
Abstract

Disclosed herein are compositions for linking DNA binding domains and cleavage domains (or cleavage half-domains) to form non-naturally occurring nucleases. Also described are methods of making and using compositions comprising these linkers.

Claims (20)

1. A fusion protein comprising

a DNA-binding domain having an N-terminus and a C-terminus, wherein the DNA-binding domain binds to a nucleotide target site;

a FokI cleavage domain having an N-terminus and a C-terminus; and

a linker between the C-terminus of the DNA-binding domain and the N-terminus of the cleavage domain, wherein the linker comprises a sequence selected from the group consisting of PKPAN (SEQ ID NO:31), RARPLN (SEQ ID NO:32); PMPPLA (SEQ ID NO:33) or PPPRP (SEQ ID NO:34).

2. The fusion protein of claim 1 , wherein the linker further comprises a ZC sequence (SEQ ID NO:35).

3. The fusion protein of claim 2 , wherein the ZC sequence is at the N-terminus of the linker.

4. The fusion protein of claim 1 , wherein the DNA-binding domain is a zinc finger protein.

5. A dimer comprising two fusion proteins according to claim 1 .

6. The dimer of claim 5 , wherein the dimer is a homodimer or heterodimer.

7. A polynucleotide encoding at least one fusion protein according to claim 1 .

8. A cell comprising a fusion protein according to claim 1 .

9. A cell comprising a polynucleotide according to claim 7 .

10. A method for targeted cleavage of cellular chromatin in a region of interest in a cell, the method comprising:

expressing a pair of nucleases in the cell under conditions such that cellular chromatin is cleaved at a the region of interest, wherein the nucleases bind to target sites in the region of interest and further wherein at least one nuclease comprises a fusion protein according to claim 1 .

11. The method of claim 10 , wherein both nucleases comprise fusions proteins according to claim 1 .

12. The method of claim 10 , wherein the target sites for the zinc finger nucleases are 3 to 20 base pairs apart.

13. The method of claim 10 , further comprising the step of introducing a donor polynucleotide into the cell, wherein all or part of the donor polynucleotide is incorporated into the region of interest following cleavage.

14. A kit for producing a nuclease, the kit comprising a fusion protein according to claim 1 contained in one or more containers, optional hardware, and instructions for use of the kit.

15. A kit for producing a nuclease, the kit comprising a polynucleotide according to claim 7 contained in one or more containers, optional hardware, and instructions for use of the kit.

16. The kit of claim 14 , further comprising a donor polynucleotide.

Assignments (2)
CHANGE OF NAME Recorded Sep 18, 2019
From: SANGAMO BIOSCIENCES, INC.
To: SANGAMO THERAPEUTICS, INC.
Reel/Frame 050414/0730 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2014
From: PASCHON, DAVID; ZHANG, LEI
To: SANGAMO BIOSCIENCES, INC.
Reel/Frame 033634/0535 →
Continuity (2)
Provisional Application 61871219 · Aug 28, 2013
Related Publication 20150064789A1 · Mar 5, 2015